Published in J Immunol on January 01, 1980
Characteristics of human large granular lymphocytes and relationship to natural killer and K cells. J Exp Med (1981) 5.76
Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells. J Exp Med (1989) 2.33
The Thy-1-bearing cell of murine epidermis. A distinctive leukocyte perhaps related to natural killer cells. J Exp Med (1985) 1.93
Mode of regulation of natural killer cell activity by interferon. J Exp Med (1980) 1.63
Cloned cell lines with natural killer activity. Specificity, function, and cell surface markers. J Exp Med (1981) 1.49
Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver. J Exp Med (1984) 1.41
Glycolipids of the mouse peritoneal macrophage. Alterations in amount and surface exposure of specific glycolipid species occur in response to inflammation and tumoricidal activation. J Exp Med (1984) 1.19
Systemic mononuclear-cell vasculitis in MRL/Mp-lpr/lpr mice. A histologic and immunocytochemical analysis. Am J Pathol (1987) 1.16
Antiglycolipid autoantibody detected in the sera from systemic lupus erythematosus patients. J Clin Invest (1980) 1.14
In vivo treatment with monoclonal antibody 3.2.3 selectively eliminates natural killer cells in rats. J Exp Med (1990) 1.10
Augmented followed by suppressed levels of natural cell-mediated cytotoxicity in mice infected with Toxoplasma gondii. Infect Immun (1982) 1.04
Identification of tissue-infiltrating lymphocytes expressing PEN5, a mucin-like glycoprotein selectively expressed on natural killer cells. Am J Pathol (1995) 0.94
Investigation of porcine natural-killer cell activity with reference to African swine-fever virus infection. Immunology (1983) 0.90
The role of cytokines, adhesion molecules, and chemokines in interleukin-2-induced lymphocytic infiltration in C57BL/6 mice. J Clin Invest (1996) 0.90
Tissue-Resident NK Cells Mediate Ischemic Kidney Injury and Are Not Depleted by Anti-Asialo-GM1 Antibody. J Immunol (2015) 0.90
Expression of T-cell associated antigens by porcine natural killer cells. Immunology (1988) 0.87
Enhanced natural killer cell activity in experimental murine encephalitozoonosis. Infect Immun (1983) 0.86
Influenza virus-induced encephalopathy in mice: interferon production and natural killer cell activity during acute infection. J Virol (1986) 0.84
The generation of natural killer (NK) cells from NK precursor cells in rat long-term bone marrow cultures. J Exp Med (1990) 0.83
High expression of NK-1.1 antigen is induced by infection with murine AIDS virus. Immunology (1993) 0.80
Spontaneous cytotoxicity of human peripheral blood mononuclear cells for the lymphoblastoid cell line CCRF-CEM: augmentation by bacterial lipopolysaccharide. Clin Exp Immunol (1981) 0.79
Depletion of B220(+)NK1.1(+) cells enhances the rejection of established melanoma by tumor-specific CD4(+) T cells. Oncoimmunology (2015) 0.77
The development of NK cell activity in thymectomized bone marrow chimaeras. Immunology (1984) 0.76
Natural killer (NK) cell activity in human long-term bone marrow cultures (LTBMC): effects of interleukin-2 (IL-2) and granulocyte-macrophage colony-stimulating factor (GM-CSF) on the progenitor cells. Immunology (1992) 0.75
In vivo treatment with interferon causes augmentation of IL-2 induced lymphokine-activated killer cells in the organs of mice. Clin Exp Immunol (1991) 0.75
Natural killer activity: early days, advances, and seminal observations. Crit Rev Oncog (2014) 0.75
Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs. Nature (1985) 9.94
Detection of monoclonal antibodies specific for carbohydrate epitopes using periodate oxidation. J Immunol Methods (1985) 5.80
Modulation of inflammation and immunity by cyclic AMP. Science (1974) 4.31
Interleukin-2 augments natural killer cell activity. Nature (1981) 4.15
External labeling of cell surface galactose and galactosamine in glycolipid and glycoprotein of human erythrocytes. J Biol Chem (1973) 4.11
Cell-type-specific markers for distinguishing and studying neurons and the major classes of glial cells in culture. Brain Res (1979) 3.66
The role of cyclic 3',5' adenosine monophosphate in the specific cytolytic activity of lymphocytes. J Immunol (1972) 3.51
Determination of aminosugar linkages in glycolipids by methylation. Aminosugar linkages of ceramide pentasaccharides of rabbit erythrocytes and of Forssman antigen. Arch Biochem Biophys (1973) 2.87
Glycolipids of hamster fibroblasts and derived malignant-transformed cell lines. Proc Natl Acad Sci U S A (1968) 2.75
The cell surface receptors for interleukin-1 alpha and interleukin-1 beta are identical. Nature (1987) 2.68
BCG-induced suppressor cells. I. Demonstration of a macrophage-like suppressor cell that inhibits cytotoxic T cell generation in vitro. J Immunol (1978) 2.60
Cell-mediated immunity and antibody responses in the respiratory tract after local and systemic immunization. J Exp Med (1971) 2.54
Using Medicare claims for outcomes research. Med Care (1994) 2.46
Quantitation of the cell-mediated immune response. I. The number of cytolytically active mouse lymphoid cells induced by immunization with allogeneic mastocytoma cells. J Immunol (1971) 2.38
Quantitative isolation of total glycosphingolipids from animal cells. J Lipid Res (1971) 2.29
Anomeric structure of globoside and ceramide grihexoside of human erythrocytes and hamster fibroblasts. J Biol Chem (1971) 2.05
Demonstration of the exposure of new antigenic determinants following antigen-antibody combination. Nature (1965) 2.04
Organizational difference of cell surface "hematoside" in normal and virally transformed cells. Biochem Biophys Res Commun (1968) 2.04
In vivo interleukin 2 administration augments the generation of alloreactive cytolytic T lymphocytes and resident natural killer cells. J Immunol (1983) 1.97
Effects of cholera toxin on in vitro models of immediate and delayed hypersensitivity. Further evidence for the role of cyclic adenosine 3',5'-monophosphate. J Clin Invest (1973) 1.94
Altered growth behavior of malignant cells associated with changes in externally labeled glycoprotein and glycolipid. Proc Natl Acad Sci U S A (1973) 1.92
Immunologic relationship between blood group substances and a fucose-containing glycolipid of human adenocarcinoma. J Immunol (1967) 1.88
Introduction of "natural" killer' cells by BCG. Nature (1976) 1.88
The role of cyclic AMP in the cytolytic activity of lymphocytes. J Immunol (1971) 1.78
Interleukin 2 induces gamma-interferon production: participation of macrophages and NK-like cells. J Immunol (1983) 1.72
Cell-mediated immunity shown by lymphocytes from the respiratory tract. Science (1970) 1.71
Community-acquired pneumonia: can it be defined with claims data? Am J Med Qual (1997) 1.71
Murine NK cell cultures: effects of interleukin-2 and interferon on cell growth and cytotoxic reactivity. J Immunol (1981) 1.70
Studies on the mechanism of lymphocyte-mediated cytolysis. II. The use of various target cell markers to study cytolytic events. J Immunol (1973) 1.69
A sphingolipid having a novel type of ceramide and lacto-N-fucopentaose 3. J Biol Chem (1971) 1.68
The effects of a series of prostaglandins on in vitro models of the allergic response and cellular immunity. Prostaglandins (1972) 1.67
Studies on the mechanism of lymphocyte-mediated cytolysis. IV. Specificity of the histamine receptor on effector T cells. J Immunol (1973) 1.63
The reactivity of rheumatoid factor with human gamma G globulin. Immunology (1965) 1.62
Characterization of a blood group I-active ganglioside. Structural requirements for I and i specificities. J Biol Chem (1979) 1.58
BCG-induced murine effector cells. II. Characterization of natural killer cells in peritoneal exudates. J Immunol (1977) 1.56
The differentiation of cytotoxic T cells in vitro. I. Amplifying factor(s) in the primary response is Lyt 1 + cell dependent. J Immunol (1979) 1.56
Molecular characterization of interleukin 2. Immunol Rev (1982) 1.52
Studies on cell adhesion and recognition. I. Extent and specificity of cell adhesion triggered by carbohydrate-reactive proteins (glycosidases and lectins) and by fibronectin. J Cell Biol (1981) 1.52
Functional heterogeneity of murine lymphoid cells. IV. Allogeneic mixed lymphocyte reactivity and cytolytic activity as functions of distinct T cell subsets. J Immunol (1973) 1.47
Relationship of provider characteristics to outcomes, process, and costs of care for community-acquired pneumonia. Med Care (1998) 1.46
Properties of a subpopulation of T cells bearing histamine receptors. J Clin Invest (1975) 1.43
The role of interleukin-2 (IL-2) in the differentiatin of cytotoxic T cells: the effect of monoclonal anti-IL-2 antibody and absorption with IL-2 dependent T cell lines. J Immunol (1981) 1.42
On the mechanism of T-cell mediated cytolysis. Transplant Rev (1973) 1.42
The measurement of hospital case mix. Med Care (1982) 1.41
Adenylate cyclase toxins from Bacillus anthracis and Bordetella pertussis. Different processes for interaction with and entry into target cells. J Biol Chem (1989) 1.39
T-Cell-mediated cytolysis: an overview of some current issues. Contemp Top Immunobiol (1977) 1.35
Studies on the mechanism of lymphocyte-mediated cytolysis. VI. A reappraisal of the requirement for protein synthesis during T cell-mediated lysis. J Immunol (1976) 1.32
Interleukin 7: effects on early events in lymphopoiesis. Immunol Today (1989) 1.32
Studies on the mechanism of lymphocyte-mediated cytolysis. 3. The role of microfilaments and microtubules. J Immunol (1973) 1.31
Selective depletion of NK cell activity in vivo and its effect on the growth of NK-sensitive and NK-resistant tumor cell variants. Int J Cancer (1982) 1.30
Human monoclonal antibody against Forssman antigen. Science (1980) 1.30
Effect of antigen on the structural configuration of homologous antibody following antigen-antibody combination. Nature (1966) 1.29
Evidence for direct linkage between antigen recognition and lytic expression in effector T cells. J Exp Med (1976) 1.28
Studies on the mechanism of lymphocyte-mediated cytolysis. IX. Relationships between antigen recognition and lytic expression in killer T cells. J Immunol (1977) 1.28
Three types of blood group I specificity among monoclonal anti-I autoantibodies revealed by analogues of a branched erythrocyte glycolipid. J Exp Med (1979) 1.28
Isotype switching of an immunoglobulin heavy chain transgene occurs by DNA recombination between different chromosomes. Cell (1990) 1.27
A simplified procedure for the preparation of immunoglobulin-class-specific antisera. J Immunol (1969) 1.26
Lymphokine-driven "differentiation" of cytotoxic T-cell clones into cells with NK-like specificity: correlations with display of membrane macromolecules. Immunol Rev (1983) 1.26
Determination of plasma membrane lipid mass and composition in cultured Chinese hamster ovary cells using high gradient magnetic affinity chromatography. J Biol Chem (1993) 1.24
Studies on cell adhesion and recognition. II. The kinetics of cell adhesion and cell spreading on surfaces coated with carbohydrate-reactive proteins (glycosidases and lectins) and fibronectin. J Cell Biol (1981) 1.22
Production of monoclonal antibodies specific for two distinct steric portions of the glycolipid ganglio-N-triosylceramide (asialo GM2). J Exp Med (1979) 1.21
Two monoclonal anticarbohydrate antibodies directed to glycosphingolipids with a lacto-N-glycosyl type II chain. J Biol Chem (1981) 1.21
Therapy of mouse lymphoma with monoclonal antibodies to glycolipid: selection of low antigenic variants in vivo. Science (1981) 1.21
Incorporating severity of illness and comorbidity in case-mix measurement. Health Care Financ Rev (1984) 1.21
Glycolipid expression in lymphoma cell variants: chemical quantity, immunologic reactivity, and correlations with susceptibility to NK cells. J Immunol (1981) 1.20
Characterization of five cloned murine cell lines showing high cytolytic activity against YAC-1 cells. J Immunol (1982) 1.20
Studies on human IgD. II. The lack of skin sensitizing and complement fixing activities of immunoglobulin D. Immunochemistry (1969) 1.20
Studies on the synthetic capacity and antigenic expression of glutaraldehyde-fixed target cells. J Immunol (1975) 1.20
Antigen-T lymphocyte interactions: inhibition by cytochalasin B. J Immunol (1973) 1.19
Studies of the mechanism of lymphocyte-mediated cytolysis. VII. Two stages in the T cell-mediated lytic cycle with distinct cation requirements. J Immunol (1976) 1.18
Cytokine-dependent thymocyte responses: characterization of IL 1 and IL 2 target subpopulations and mechanism of action. J Immunol (1982) 1.18
The biochemical and biological characterization of lymphocyte regulatory molecules. VI. Generation of a B cell hybridoma whose antibody product inhibits interleukin 2 activity. J Immunol (1981) 1.16
Transport of newly synthesized glucosylceramide to the plasma membrane by a non-Golgi pathway. Proc Natl Acad Sci U S A (1994) 1.15
Factors affecting expression of glycolipid tumor antigens: influence of ceramide composition and coexisting glycolipid on the antigenicity of gangliotriaosylceramide in murine lymphoma cells. Cancer Res (1983) 1.14
Isoantigenic expression of Forssman glycolipid in human gastric and colonic mucosa: its possible identity with "A-like antigen" in human cancer. Proc Natl Acad Sci U S A (1977) 1.14
Increase in histamine receptors on thymus-derived effector lymphocytes during the primary immune response to alloantigens. Nature (1973) 1.10
Immune response of the human respiratory tract. II. Cell-mediated immunity in the lower respiratory tract to tuberculin and mumps and influenza viruses. J Infect Dis (1973) 1.10
Effect of anti-lymphotoxin on cell-mediated cytotoxicity. Evidence for two pathways, one involving lymphotoxin and the other requiring intimate contact between the plasma membranes of killer and target cells. Cell Immunol (1976) 1.09
Studies on the mechanism of lymphocyte-mediated cytolysis. XI. The role of lectin in lectin-dependent cell-mediated cytotoxicity. J Immunol (1978) 1.09
The effect of capping H-2 antigens on the susceptibility of target cells to humoral and T cell-mediated lysis. Nat New Biol (1973) 1.09
Antigenic determinants specific for aggregated gamma G-globulins. J Immunol (1968) 1.09
A specific cell surface glycoconjugate controlling cell motility: evidence by functional monoclonal antibodies that inhibit cell motility and tumor cell metastasis. Biochemistry (1991) 1.07
Effect of antibody-complement on multiple vs. single compartment liposomes. Application of a fluorometric assay for following changes in liposomal permeability. Biochemistry (1974) 1.07
Association of the glycolipid pattern with antigenic alterations in mouse fibroblasts transformed by murine sarcoma virus. Cancer Res (1977) 1.07
Structural and conformational specificity of the antigen for rheumatoid factor. Ann N Y Acad Sci (1969) 1.07
Monoclonal antibody directed against interleukin 2. I. Inhibition of T lymphocyte mitogenesis and the in vitro differentiation of alloreactive cytolytic T cells. J Exp Med (1981) 1.06
Studies on the mechanism of lymphocyte-mediated cytolysis. V. The use of cytochalasins A and B to dissociate glucose transport from the lytic event. J Immunol (1975) 1.06
On neutral fucoglycolipids having long, branched carbohydrate chains: H-active and I-active glycosphingolipids of human erythrocyte membranes. Biochemistry (1975) 1.05
Studies on the cytotoxic activity of human lymphocytes. II. Interactions between IgG and Fc receptors leading to inhibition of K cell function. J Immunol (1977) 1.04
Studies on cell adhesion and recognition. III. The occurrence of alpha-mannosidase at the fibroblast cell surface, and its possible role in cell recognition. J Cell Biol (1981) 1.04
Studies on the immunogenicity of antigen-antibody precipitates. 1. The suppressive effect of anti-L and anti-H chain antibodies on the immunogenicity of human gammaG globulin. J Immunol (1968) 1.04
BCG-induced murine effector cells. I. Cytolytic activity in peritoneal exudates: an early response to BCG. J Immunol (1977) 1.03
Isolation and characterization of two types of MDCK epithelial cell clones based on glycosphingolipid pattern. Biochim Biophys Acta (1986) 1.03